Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme

Radiation Oncology Investigations

Volumn 7, Issue 1, 1999, Pages 36-41

  Nieder, Carsten ^a,b   Nestle, Ursula ^a   Ketter, Ralf ^a   Kolles, Harry ^a   Gentner, Sascha J ^a   Steudel, Wolf I ^a   Schnabel, Klaus ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Accelerated radiotherapy; Hyperfractionated radiotherapy; glioblastoma multiforme; Malignant glioma; Radiotherapy

Indexed keywords

DEXAMETHASONE;

ADOLESCENT; ADULT; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE COURSE; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; MALE; NEUROTOXICITY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; TUMOR BIOPSY;

ADOLESCENT; ADULT; AGED; BRAIN; BRAIN NEOPLASMS; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; GLIOBLASTOMA; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032992574     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1999)7:1<36::AID-ROI5>3.0.CO;2-O     Document Type: Article

References (17)

1. Walker MD, Strike TS, Sheline GE: An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5:1725-1731, 1979.
2. Nelson DF, Diener-West M, Horton J, Chang CH, Schoenfeld D, Nelson JS: Combined modality approach to treatment of malignant gliomas. Reevaluation of RTOG 74-01/ECOG 1374 with long-term follow-up. NCI Monogr 6:279-284, 1988.
3. Shapiro WR, Green SB, Burger P, Mahaley MS, Selker RG, van Gilder JC, Robertson JT, Strike TA: Randomized trial of three chemotherapy regimens in postoperative treatment of malignant glioma. J Neurosurg 71:1-9, 1989.
4. Fallai C, Olmi P: Hyperfractionated and accelerated radiation therapy in central nervous system tumours (malignant gliomas, pediatric tumours, and brain metastases). Radiother Oncol 43:235-246, 1997.
5. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P: Grading of astrocytomas. Cancer 63:2152-2165, 1988.
6. Kleihues P, Burger PC, Scheithauer B: Histological typing of tumours of the central nervous system. WHO international classification of tumours, 2nd ed. Berlin, Heidelberg, and New York: Springer 1993.
7. Guderson S, Lote K, Hannisdal E: Prognostic factors for glioblastoma multiforme. Acta Oncol [Suppl] 35: 123-127, 1996.
8. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS, Weinstein AS, Nelson DF: Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive RTOG clinical trials. Int J Radiat Oncol Biol Phys 26: 239-244, 1993.
9. Walker MD, Green SB, Byar DP, Alexander E, Batzdorf U, Brooks WH, Shapiro WR, Smith AR, Wilson CB, Strike TA: Randomised comparisons of radiotherapy and nitrosureas for the treatment of malignant glioma after surgery. N Engl J Med 303:1323-1329, 1980.
10. Brada M, Thomas G, Elyan S, James N, Hines F, Ashley S, Marsh H, Bell BA, Stenning S: Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma. Br J Cancer 71:1330-1334, 1995.
11. Shibamoto Y, Nishimura Y, Tsutsui K, Sasai K, Takahashi M, Abe M: Comparison of accelerated hyperfractionated radiotherapy and conventional radiotherapy for supratentorial malignant glioma. Jpn J Clin Oncol 27: 31-36, 1997.
12. Beck-Bornholdt HP, Dubben HH, Liertz-Petersen C, Willers H: Hyperfractionation: where do we stand? Radiother Oncol 43:1-21, 1997.
13. Nelson DF, Curran WJ, Scott C, Nelson JF, Weinstein AS, Ahmad K, Consine LS, Murray K, Powlis WD, Mohiuddin M, Fischbach J: Hyperfractionated radiation therapy and bis-chlorethyl nitrosurea in the treatment of malignant glioma. Int J Radiat Oncol Biol Phys 25:193-207, 1993.
14. Curran WJ, Scott CB, Yung WK: No survival benefit of hyperfractionated radiotherapy to 72 Gy and carmustine versus standard radiotherapy and carmustine for malignant glioma patients: preliminary results of RTOG 90-06 [abstract]. Proc Am Soc Clin Oncol 15: 154, 1996.
15. Werner-Wasik M, Scott CB, Nelson DF, Gaspar LE, Murray KJ, Fischbach J, Nelson JS, Weinstein AS, Curran WJ: Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Cancer 77:1535-1543, 1996.
16. Gonzalez Gonzalez D, Menten J, Bosch DA, van der Schueren E, Troost D, Hulshof MC, Bernier J: Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study. Radiother Oncol 32:98-105, 1994.
17. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71:2585-2597, 1993.